As reported by IPWatchdog, Moderna is facing lawsuits in the United States from biotech firms, Arbutus Biopharma Corporation and Genevant Sciences GmbH.
Both companies allege that Moderna has infringed six of their U.S. patents relating to lipid nanoparticle (“LNP”) delivery technology. LNP delivery systems are crucial for mRNA therapies like Moderna’s COVID-19 vaccine by allowing treatments to bypass the human immune system without being destroyed.
Moderna has reportedly denied all allegations and vowed to vigorously defend itself against the claims made against it in court.
The plaintiffs in this action are seeking compensation, rather than an injunction, which is typically sought in such actions. If infringement is found, compensation through damages would likely be assessed through a “reasonable royalty”.
Amendments to the Trademarks Regulations will take effect on April 1, 2025. These changes are part of broader updates to the Trademarks Act, introduced through the Budget Implementation Act, 2018, No…
Heineken’s Lagunitas Brewery has reportedly advanced its trademark and copyright claims over its "La Tropical" beer in a legal battle involving Cuban-origin brands. As reported by Bloomberg, the…
Marvel and DC have reportedly lost their long-held trademarks for “Super Hero”. For decades, the two comic giants jointly owned the trademark, with DC using it for its DC Super Hero Cafe and…
In January 2025, the Trademarks Opposition Board (TMOB) is launching a pilot project in which the Registrar of Trademarks will issue 50–100 section 45 notices per month for randomly selected trademark…
There has been a reported surge in trademark phishing scams. The Canadian Intellectual Property Office (“CIPO”) issued a statement warning of an email phishing scam targeting members of the public by…
A few recent patent applications reveal that the Honda Element may be making its return to the automotive industry: The first patent application is a “camper for a vehicle”. The second…
